You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (33)

Journals (0)

1-10 of 33 results for third-generation EGFR-TKIs

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Expert consensus on the use of third-generation EGFR-TKIs in EGFR-mutated advanced non-small cell lung cancer with various T790M mutations post-resistance to first-/second-generation EGFR-TKIs

Open access

Review article

First published 2024

Expert consensus on the use of third-generation EGFR-TKIs in EGFR-mutated advanced non-small cell lung cancer with various T790M mutations post-resistance to first-/second-generation EGFR-TKIs

Jietao Ma, Letian Huang, Chengbo Han

Therapeutic Advances in Medical Oncology

Select article: Treatment options for EGFR mutation-positive NSCLC patients with leptomeningeal metastases after third-generation TKI resistance: a retrospective real-world study

Open access

Research article

First published 2025

Treatment options for EGFR mutation-positive NSCLC patients with leptomeningeal metastases after third-generation TKI resistance: a retrospective real-world study

Wenhua Yun, Ailing Liu, Junxu Wen [...]

Therapeutic Advances in Medical Oncology

Select article: Comparison of first and third generation EGFR-TKIs for the treatment of advanced non-small cell lung cancer: A real-world study

Retricted access

Research article

First published 2025

Comparison of first and third generation EGFR-TKIs for the treatment of advanced non-small cell lung cancer: A real-world study

Maitri Shah, Kashvi Shah, Hetvi Dave [...]

Journal of Oncology Pharmacy Practice

Select article: Treatment in EGFR-mutated Non-small Cell Lung Cancer: How to Block the Receptor and overcome Resistance Mechanisms

Retricted access

Review article

First published 2017-7

Treatment in EGFR-mutated Non-small Cell Lung Cancer: How to Block the Receptor and overcome Resistance Mechanisms

Claudia Proto, Giuseppe Lo Russo, Giulia Corrao [...]

Tumori Journal

Select article: Clinical approaches to treat patients with non-small cell lung cancer and epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance

Free access

Review article

First published 2015-10

Clinical approaches to treat patients with non-small cell lung cancer and epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance

Alfredo Tartarone, Rosa Lerose

Therapeutic Advances in Respiratory Disease

Select article: EGFR tyrosine kinase inhibitors in non-small cell lung cancer: treatment paradigm,current evidence,and challenges

Retricted access

Review article

First published 2021-10

EGFR tyrosine kinase inhibitors in non-small cell lung cancer: treatment paradigm,current evidence,and challenges

Arafat Tfayli, Razan Mohty

Tumori Journal

Select article: Osimertinib: A third-generation tyrosine kinase inhibitor for treatment of epidermal growth factor receptor-mutated non-small cell lung cancer with the acquired Thr790Met mutation

Retricted access

Review article

First published 2018-7

Osimertinib: A third-generation tyrosine kinase inhibitor for treatment of epidermal growth factor receptor-mutated non-small cell lung cancer with the acquired Thr790Met mutation

Meredith K Bollinger, Amanda S Agnew, Gerard P Mascara

Journal of Oncology Pharmacy Practice

Select article: Treatment choice in epidermal growth factor receptor mutation-positive non-small cell lung carcinoma: latest evidence and clinical implications

Free access

Review article

First published 2017-3

Treatment choice in epidermal growth factor receptor mutation-positive non-small cell lung carcinoma: latest evidence and clinical implications

Oscar Juan, Sanjay Popat

Therapeutic Advances in Medical Oncology

Select article: Turning EGFR mutation-positive non-small-cell lung cancer into a chronic disease: optimal sequential therapy with EGFR tyrosine kinase inhibitors

Open access

Review article

First published 2018

Turning EGFR mutation-positive non-small-cell lung cancer into a chronic disease: optimal sequential therapy with EGFR tyrosine kinase inhibitors

Vera Hirsh

Therapeutic Advances in Medical Oncology

Select article: Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale,evidence and place in therapy

Open access

Review article

First published 2017-6

Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale,evidence and place in therapy

Biagio Ricciuti, Sara Baglivo, Luca Paglialunga [...]

Therapeutic Advances in Medical Oncology

1
2
3
4
10 / page

Article type

Publication date

Subjects

Access